共 11 条
[1]
[2]
Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial[J] Ann VSchwartz;Douglas CBauer;Steven RCummings;Jane ACauley;Kristine EEnsrud;LisaPalermo;Robert BWallace;Marc CHochberg;Adrianne CFeldstein;AntonioLombardi;Dennis MBlack J Bone Miner Res 2010,
[3]
Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long‐term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long‐term extension (FLEX)[J] PRoschger;ALombardi;BMMisof;GMaier;NFratzl‐Zelman;PFratzl;KKlaushofer J Bone Miner Res 2010,
[4]
Fragility fractures of the hip and femur: incidence and patient characteristics[J] J. W. Nieves;J. P. Bilezikian;J. M. Lane;T. A. Einhorn;Y. Wang;M. Steinbuch;F. Cosman Osteoporosis International 2010,
[5]
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis[J] Dennis M. Black;Pierre D. Delmas;Richard Eastell;Ian R. Reid;Steven Boonen;Jane A. Cauley;Felicia Cosman;Péter Lakatos;Ping Chung Leung;Zulema Man;Carlos Mautalen;Peter Mesenbrink;Huilin Hu;John Caminis;Karen Tong;Theresa Rosario-Jansen;Joel Krasnow;Trisha F. Hue;Deborah Sellmeyer;Erik Fink Eriksen;Steven R. Cummings The New England Journal of Medicine 2007,
[6]
Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women[J] Socrates E. Papapoulos;Sara A. Quandt;Uri A. Liberman;Marc C. Hochberg;Desmond E. Thompson Osteoporosis International 2005,
[7]
Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized; Double-Blind; Placebo-Controlled Study[J] Susan Greenspan;Ellen Field-Munves;Richard Tonino;Mary Smith;Richard Petruschke;Lixia Wang;John Yates;Anne E. de Papp;Joanne Palmisano Mayo Clinic Proceedings 2002,
[8]
Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial[J] DENNIS M BLACK;DESMOND E THOMPSON;DOUGLAS C BAUER;KRIS ENSRUD;THOMAS MUSLINER;MARC C HOCHBERG;MICHAEL C NEVITT;SHAILAJA SURYAWANSHI;STEVEN R CUMMINGS The Journal of Clinical Endocrinology & Metabolism 2000,
[9]
Multinational; Placebo-Controlled; Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study[J] H. A. P. Pols;D. Felsenberg;D. A. Hanley;J. ?tepán;M. Mu?oz-Torres;T. J. Wilkin;G. Qin-sheng;A. M. Galich;K. Vandormael;A. J. Yates;B. Stych Osteoporosis International 1999,
[10]
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures[J] Dennis M Black;Steven R Cummings;David B Karpf;Jane A Cauley;Desmond E Thompson;Michael C Nevitt;Douglas C Bauer;Harry K Genant;William L Haskell;Robert Marcus;Susan M Ott;James C Torner;Sara A Quandt;Theodore F Reiss;Kristine E Ensrud The Lancet 1996,